Bipolar disorder (formerly called manic-depressive illness or manic depression) is a mental disorder that causes unusual shifts in mood, energy, activity levels, concentration, and the ability to carry out day-to-day tasks.

The market is mainly driven by the significant applications of Bipolar Disorder in various end use industries. The expanding demands from the Mood Stabilizers, Anticonvulsants, Antipsychotic drugs and Antidepressant drugs, are propelling Bipolar Disorder market. Bipolar I Disorder, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Bipolar II Disorder segment is estimated at % CAGR for the next seven-year period.

Asia Pacific shows high growth potential for Bipolar Disorder market, driven by demand from China, the second largest economy with some signs of stabilising, the Bipolar Disorder market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.

Report Objectives

This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Bipolar Disorder, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.

Key Features of The Study:

This report provides in-depth analysis of the global Bipolar Disorder market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.

This report profiles key players in the global Bipolar Disorder market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Bipolar Disorder sales data, market share and ranking.

This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.

This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.

Key companies of Bipolar Disorder covered in this report include Glaxo SmithKline (GSK), Pfizer Inc., Janssen Pharmaceuticals, Eli Lilly, Allergan Plc., Novartis AG, AbbVie Inc., Otsuka Holdings Ltd and AstraZeneca, etc.

The global Bipolar Disorder market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.

Market Segmentation

Company Profiles:

Glaxo SmithKline (GSK)

Pfizer Inc.

Janssen Pharmaceuticals

Eli Lilly

Allergan Plc.

Novartis AG

AbbVie Inc.

Otsuka Holdings Ltd

AstraZeneca

Scope of Bipolar Disorder - Market Report

Report Metric	Details
Report Name	Bipolar Disorder - Market
Forecasted market size in 2029	US$ 6994.7 million
CAGR	2.7%
Forecasted years	2023 - 2029
Global Bipolar Disorder market, by region:	North America (U.S., Canada, Mexico) Europe (Germany, France, UK, Italy, etc.) Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.) South America (Brazil, etc.) Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Bipolar Disorder market, Segment by Type:	Bipolar I Disorder Bipolar II Disorder Cyclothymic Disorder
Global Bipolar Disorder market, by Application	Mood Stabilizers Anticonvulsants Antipsychotic drugs Antidepressant drugs Antianxiety drugs Others
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Bipolar Disorder companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion

FAQ for this report

What is the Bipolar Disorder - Market size in 2029?

Ans: The Bipolar Disorder - Market size in 2029 will be US$ 6994.7 million.

What are the Application segmentation covered in the Bipolar Disorder - Market report?

Ans: The Applications covered in the Bipolar Disorder - Market report are Mood Stabilizers, Anticonvulsants, Antipsychotic drugs, Antidepressant drugs, Antianxiety drugs, Others

What are the Type segmentation covered in the Bipolar Disorder - Market report?

Ans: The Types covered in the Bipolar Disorder - Market report are Bipolar I Disorder, Bipolar II Disorder, Cyclothymic Disorder

1 Market Overview of Bipolar Disorder

1.1 Bipolar Disorder Market Overview

1.1.1 Bipolar Disorder Product Scope

1.1.2 Bipolar Disorder Market Status and Outlook

1.2 Global Bipolar Disorder Market Size Overview by Region 2018 VS 2022 VS 2029

1.3 Global Bipolar Disorder Market Size by Region (2018-2029)

1.4 Global Bipolar Disorder Historic Market Size by Region (2018-2023)

1.5 Global Bipolar Disorder Market Size Forecast by Region (2024-2029)

1.6 Key Regions, Bipolar Disorder Market Size (2018-2029)

1.6.1 North America Bipolar Disorder Market Size (2018-2029)

1.6.2 Europe Bipolar Disorder Market Size (2018-2029)

1.6.3 Asia-Pacific Bipolar Disorder Market Size (2018-2029)

1.6.4 Latin America Bipolar Disorder Market Size (2018-2029)

1.6.5 Middle East & Africa Bipolar Disorder Market Size (2018-2029)

2 Bipolar Disorder Market by Type

2.1 Introduction

2.1.1 Bipolar I Disorder

2.1.2 Bipolar II Disorder

2.1.3 Cyclothymic Disorder

2.2 Global Bipolar Disorder Market Size by Type: 2018 VS 2022 VS 2029

2.2.1 Global Bipolar Disorder Historic Market Size by Type (2018-2023)

2.2.2 Global Bipolar Disorder Forecasted Market Size by Type (2024-2029)

2.3 Key Regions Market Size by Type

2.3.1 North America Bipolar Disorder Revenue Breakdown by Type (2018-2029)

2.3.2 Europe Bipolar Disorder Revenue Breakdown by Type (2018-2029)

2.3.3 Asia-Pacific Bipolar Disorder Revenue Breakdown by Type (2018-2029)

2.3.4 Latin America Bipolar Disorder Revenue Breakdown by Type (2018-2029)

2.3.5 Middle East and Africa Bipolar Disorder Revenue Breakdown by Type (2018-2029)

3 Bipolar Disorder Market Overview by Application

3.1 Introduction

3.1.1 Mood Stabilizers

3.1.2 Anticonvulsants

3.1.3 Antipsychotic drugs

3.1.4 Antidepressant drugs

3.1.5 Antianxiety drugs

3.1.6 Others

3.2 Global Bipolar Disorder Market Size by Application: 2018 VS 2022 VS 2029

3.2.1 Global Bipolar Disorder Historic Market Size by Application (2018-2023)

3.2.2 Global Bipolar Disorder Forecasted Market Size by Application (2024-2029)

3.3 Key Regions Market Size by Application

3.3.1 North America Bipolar Disorder Revenue Breakdown by Application (2018-2029)

3.3.2 Europe Bipolar Disorder Revenue Breakdown by Application (2018-2029)

3.3.3 Asia-Pacific Bipolar Disorder Revenue Breakdown by Application (2018-2029)

3.3.4 Latin America Bipolar Disorder Revenue Breakdown by Application (2018-2029)

3.3.5 Middle East and Africa Bipolar Disorder Revenue Breakdown by Application (2018-2029)

4 Bipolar Disorder Competition Analysis by Players

4.1 Global Bipolar Disorder Market Size by Players (2018-2023)

4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Bipolar Disorder as of 2022)

4.3 Date of Key Players Enter into Bipolar Disorder Market

4.4 Global Top Players Bipolar Disorder Headquarters and Area Served

4.5 Key Players Bipolar Disorder Product Solution and Service

4.6 Competitive Status

4.6.1 Bipolar Disorder Market Concentration Rate

4.6.2 Mergers & Acquisitions, Expansion Plans

5 Company (Top Players) Profiles

5.1 Glaxo SmithKline (GSK)

5.1.1 Glaxo SmithKline (GSK) Profile

5.1.2 Glaxo SmithKline (GSK) Main Business

5.1.3 Glaxo SmithKline (GSK) Bipolar Disorder Products, Services and Solutions

5.1.4 Glaxo SmithKline (GSK) Bipolar Disorder Revenue (US$ Million) & (2018-2023)

5.1.5 Glaxo SmithKline (GSK) Recent Developments

5.2 Pfizer Inc.

5.2.1 Pfizer Inc. Profile

5.2.2 Pfizer Inc. Main Business

5.2.3 Pfizer Inc. Bipolar Disorder Products, Services and Solutions

5.2.4 Pfizer Inc. Bipolar Disorder Revenue (US$ Million) & (2018-2023)

5.2.5 Pfizer Inc. Recent Developments

5.3 Janssen Pharmaceuticals

5.3.1 Janssen Pharmaceuticals Profile

5.3.2 Janssen Pharmaceuticals Main Business

5.3.3 Janssen Pharmaceuticals Bipolar Disorder Products, Services and Solutions

5.3.4 Janssen Pharmaceuticals Bipolar Disorder Revenue (US$ Million) & (2018-2023)

5.3.5 Eli Lilly Recent Developments

5.4 Eli Lilly

5.4.1 Eli Lilly Profile

5.4.2 Eli Lilly Main Business

5.4.3 Eli Lilly Bipolar Disorder Products, Services and Solutions

5.4.4 Eli Lilly Bipolar Disorder Revenue (US$ Million) & (2018-2023)

5.4.5 Eli Lilly Recent Developments

5.5 Allergan Plc.

5.5.1 Allergan Plc. Profile

5.5.2 Allergan Plc. Main Business

5.5.3 Allergan Plc. Bipolar Disorder Products, Services and Solutions

5.5.4 Allergan Plc. Bipolar Disorder Revenue (US$ Million) & (2018-2023)

5.5.5 Allergan Plc. Recent Developments

5.6 Novartis AG

5.6.1 Novartis AG Profile

5.6.2 Novartis AG Main Business

5.6.3 Novartis AG Bipolar Disorder Products, Services and Solutions

5.6.4 Novartis AG Bipolar Disorder Revenue (US$ Million) & (2018-2023)

5.6.5 Novartis AG Recent Developments

5.7 AbbVie Inc.

5.7.1 AbbVie Inc. Profile

5.7.2 AbbVie Inc. Main Business

5.7.3 AbbVie Inc. Bipolar Disorder Products, Services and Solutions

5.7.4 AbbVie Inc. Bipolar Disorder Revenue (US$ Million) & (2018-2023)

5.7.5 AbbVie Inc. Recent Developments

5.8 Otsuka Holdings Ltd

5.8.1 Otsuka Holdings Ltd Profile

5.8.2 Otsuka Holdings Ltd Main Business

5.8.3 Otsuka Holdings Ltd Bipolar Disorder Products, Services and Solutions

5.8.4 Otsuka Holdings Ltd Bipolar Disorder Revenue (US$ Million) & (2018-2023)

5.8.5 Otsuka Holdings Ltd Recent Developments

5.9 AstraZeneca

5.9.1 AstraZeneca Profile

5.9.2 AstraZeneca Main Business

5.9.3 AstraZeneca Bipolar Disorder Products, Services and Solutions

5.9.4 AstraZeneca Bipolar Disorder Revenue (US$ Million) & (2018-2023)

5.9.5 AstraZeneca Recent Developments

6 North America

6.1 North America Bipolar Disorder Market Size by Country (2018-2029)

6.2 United States

6.3 Canada

7 Europe

7.1 Europe Bipolar Disorder Market Size by Country (2018-2029)

7.2 Germany

7.3 France

7.4 U.K.

7.5 Italy

7.6 Russia

7.7 Nordic Countries

7.8 Rest of Europe

8 Asia-Pacific

8.1 Asia-Pacific Bipolar Disorder Market Size by Region (2018-2029)

8.2 China

8.3 Japan

8.4 South Korea

8.5 Southeast Asia

8.6 India

8.7 Australia

8.8 Rest of Asia-Pacific

9 Latin America

9.1 Latin America Bipolar Disorder Market Size by Country (2018-2029)

9.2 Mexico

9.3 Brazil

9.4 Rest of Latin America

10 Middle East & Africa

10.1 Middle East & Africa Bipolar Disorder Market Size by Country (2018-2029)

10.2 Turkey

10.3 Saudi Arabia

10.4 UAE

10.5 Rest of Middle East & Africa

11 Bipolar Disorder Market Dynamics

11.1 Bipolar Disorder Industry Trends

11.2 Bipolar Disorder Market Drivers

11.3 Bipolar Disorder Market Challenges

11.4 Bipolar Disorder Market Restraints

12 Research Finding /Conclusion

13 Methodology and Data Source

13.1 Methodology/Research Approach

13.1.1 Research Programs/Design

13.1.2 Market Size Estimation

13.1.3 Market Breakdown and Data Triangulation

13.2 Data Source

13.2.1 Secondary Sources

13.2.2 Primary Sources

13.3 Disclaimer

13.4 Author List

FEATURED COMPANIES

Glaxo SmithKline (GSK)

Pfizer Inc

Janssen Pharmaceuticals

List of Tables

Table 1. Global Market Bipolar Disorder Market Size (US$ Million) Comparison by Region 2018 VS 2022 VS 2029

Table 2. Global Bipolar Disorder Market Size by Region (2018-2023) & (US$ Million)

Table 3. Global Bipolar Disorder Market Size Share by Region (2018-2023)

Table 4. Global Bipolar Disorder Forecasted Market Size by Region (2024-2029) & (US$ Million)

Table 5. Global Bipolar Disorder Forecasted Market Size Share by Region (2024-2029)

Table 6. Global Bipolar Disorder Market Size (US$ Million) by Type: 2018 VS 2022 VS 2029

Table 7. Global Bipolar Disorder Market Size by Type (2018-2023) & (US$ Million)

Table 8. Global Bipolar Disorder Revenue Market Share by Type (2018-2023)

Table 9. Global Bipolar Disorder Forecasted Market Size by Type (2024-2029) & (US$ Million)

Table 10. Global Bipolar Disorder Revenue Market Share by Type (2024-2029)

Table 11. North America Bipolar Disorder Revenue by Type (2018-2023) & (US$ Million)

Table 12. North America Bipolar Disorder Revenue by Type (2024-2029) & (US$ Million)

Table 13. Europe Bipolar Disorder Revenue by Type (2018-2023) & (US$ Million)

Table 14. Europe Bipolar Disorder Revenue by Type (2024-2029) & (US$ Million)

Table 15. Asia-Pacific Bipolar Disorder Revenue by Type (2018-2023) & (US$ Million)

Table 16. Asia-Pacific Bipolar Disorder Revenue by Type (2024-2029) & (US$ Million)

Table 17. Latin America Bipolar Disorder Revenue by Type (2018-2023) & (US$ Million)

Table 18. Latin America Bipolar Disorder Revenue by Type (2024-2029) & (US$ Million)

Table 19. Middle East and Africa Bipolar Disorder Revenue by Type (2018-2023) & (US$ Million)

Table 20. Middle East and Africa Bipolar Disorder Revenue by Type (2024-2029) & (US$ Million)

Table 21. Global Bipolar Disorder Market Size (US$ Million) by Application: 2018 VS 2022 VS 2029

Table 22. Global Bipolar Disorder Market Size by Application (2018-2023) & (US$ Million)

Table 23. Global Bipolar Disorder Revenue Market Share by Application (2018-2023)

Table 24. Global Bipolar Disorder Forecasted Market Size by Application (2024-2029) & (US$ Million)

Table 25. Global Bipolar Disorder Revenue Market Share by Application (2024-2029)

Table 26. North America Bipolar Disorder Revenue by Application (2018-2023) & (US$ Million)

Table 27. North America Bipolar Disorder Revenue by Application (2024-2029) & (US$ Million)

Table 28. Europe Bipolar Disorder Revenue by Application (2018-2023) & (US$ Million)

Table 29. Europe Bipolar Disorder Revenue by Application (2024-2029) & (US$ Million)

Table 30. Asia-Pacific Bipolar Disorder Revenue by Application (2018-2023) & (US$ Million)

Table 31. Asia-Pacific Bipolar Disorder Revenue by Application (2024-2029) & (US$ Million)

Table 32. Latin America Bipolar Disorder Revenue by Application (2018-2023) & (US$ Million)

Table 33. Latin America Bipolar Disorder Revenue by Application (2024-2029) & (US$ Million)

Table 34. Middle East and Africa Bipolar Disorder Revenue by Application (2018-2023) & (US$ Million)

Table 35. Middle East and Africa Bipolar Disorder Revenue by Application (2024-2029) & (US$ Million)

Table 36. Global Bipolar Disorder Revenue (US$ Million) by Players (2018-2023)

Table 37. Global Bipolar Disorder Revenue Market Share by Players (2018-2023)

Table 38. Global Top Players Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Bipolar Disorder as of 2022)

Table 39. Date of Key Players Enter into Bipolar Disorder Market

Table 40. Global Bipolar Disorder Key Players Headquarters and Area Served

Table 41. Bipolar Disorder Product Solution and Service

Table 42. Global Bipolar Disorder Players Market Concentration Ratio (CR5 and HHI)

Table 43. Mergers & Acquisitions, Expansion Plans

Table 44. Glaxo SmithKline (GSK) Basic Information List

Table 45. Glaxo SmithKline (GSK) Description and Business Overview

Table 46. Glaxo SmithKline (GSK) Bipolar Disorder Products, Services and Solutions

Table 47. Revenue (US$ Million) in Bipolar Disorder Business of Glaxo SmithKline (GSK) (2018-2023)

Table 48. Glaxo SmithKline (GSK) Recent Developments

Table 49. Pfizer Inc. Basic Information List

Table 50. Pfizer Inc. Description and Business Overview

Table 51. Pfizer Inc. Bipolar Disorder Products, Services and Solutions

Table 52. Revenue (US$ Million) in Bipolar Disorder Business of Pfizer Inc. (2018-2023)

Table 53. Pfizer Inc. Recent Developments

Table 54. Janssen Pharmaceuticals Basic Information List

Table 55. Janssen Pharmaceuticals Description and Business Overview

Table 56. Janssen Pharmaceuticals Bipolar Disorder Products, Services and Solutions

Table 57. Revenue (US$ Million) in Bipolar Disorder Business of Janssen Pharmaceuticals (2018-2023)

Table 58. Janssen Pharmaceuticals Recent Developments

Table 59. Eli Lilly Basic Information List

Table 60. Eli Lilly Description and Business Overview

Table 61. Eli Lilly Bipolar Disorder Products, Services and Solutions

Table 62. Revenue (US$ Million) in Bipolar Disorder Business of Eli Lilly (2018-2023)

Table 63. Eli Lilly Recent Developments

Table 64. Allergan Plc. Basic Information List

Table 65. Allergan Plc. Description and Business Overview

Table 66. Allergan Plc. Bipolar Disorder Products, Services and Solutions

Table 67. Revenue (US$ Million) in Bipolar Disorder Business of Allergan Plc. (2018-2023)

Table 68. Allergan Plc. Recent Developments

Table 69. Novartis AG Basic Information List

Table 70. Novartis AG Description and Business Overview

Table 71. Novartis AG Bipolar Disorder Products, Services and Solutions

Table 72. Revenue (US$ Million) in Bipolar Disorder Business of Novartis AG (2018-2023)

Table 73. Novartis AG Recent Developments

Table 74. AbbVie Inc. Basic Information List

Table 75. AbbVie Inc. Description and Business Overview

Table 76. AbbVie Inc. Bipolar Disorder Products, Services and Solutions

Table 77. Revenue (US$ Million) in Bipolar Disorder Business of AbbVie Inc. (2018-2023)

Table 78. AbbVie Inc. Recent Developments

Table 79. Otsuka Holdings Ltd Basic Information List

Table 80. Otsuka Holdings Ltd Description and Business Overview

Table 81. Otsuka Holdings Ltd Bipolar Disorder Products, Services and Solutions

Table 82. Revenue (US$ Million) in Bipolar Disorder Business of Otsuka Holdings Ltd (2018-2023)

Table 83. Otsuka Holdings Ltd Recent Developments

Table 84. AstraZeneca Basic Information List

Table 85. AstraZeneca Description and Business Overview

Table 86. AstraZeneca Bipolar Disorder Products, Services and Solutions

Table 87. Revenue (US$ Million) in Bipolar Disorder Business of AstraZeneca (2018-2023)

Table 88. AstraZeneca Recent Developments

Table 89. North America Bipolar Disorder Market Size by Country (2018-2023) & (US$ Million)

Table 90. North America Bipolar Disorder Market Size by Country (2024-2029) & (US$ Million)

Table 91. Europe Bipolar Disorder Market Size by Country (2018-2023) & (US$ Million)

Table 92. Europe Bipolar Disorder Market Size by Country (2024-2029) & (US$ Million)

Table 93. Asia-Pacific Bipolar Disorder Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029

Table 94. Asia-Pacific Bipolar Disorder Market Size by Region (2018-2023) & (US$ Million)

Table 95. Asia-Pacific Bipolar Disorder Market Size by Region (2024-2029) & (US$ Million)

Table 96. Asia-Pacific Bipolar Disorder Market Share by Region (2018-2023)

Table 97. Asia-Pacific Bipolar Disorder Market Share by Region (2024-2029)

Table 98. Latin America Bipolar Disorder Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029

Table 99. Latin America Bipolar Disorder Market Size by Country (2018-2023) & (US$ Million)

Table 100. Latin America Bipolar Disorder Market Size by Country (2024-2029) & (US$ Million)

Table 101. Middle East & Africa Bipolar Disorder Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029

Table 102. Middle East & Africa Bipolar Disorder Market Size by Country (2018-2023) & (US$ Million)

Table 103. Middle East & Africa Bipolar Disorder Market Size by Country (2024-2029) & (US$ Million)

Table 104. Bipolar Disorder Market Trends

Table 105. Bipolar Disorder Market Drivers

Table 106. Bipolar Disorder Market Challenges

Table 107. Bipolar Disorder Market Restraints

Table 108. Research Programs/Design for This Report

Table 109. Key Data Information from Secondary Sources

Table 110. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Bipolar Disorder Market Size Year-over-Year 2018-2029 & (US$ Million)

Figure 2. Global Bipolar Disorder Market Size (US$ Million), 2018 VS 2022 VS 2029

Figure 3. Global Bipolar Disorder Market Share by Regions: 2022 VS 2029

Figure 4. Global Bipolar Disorder Forecasted Market Size Share by Region (2024-2029)

Figure 5. North America Bipolar Disorder Market Size Growth Rate (2018-2029) & (US$ Million)

Figure 6. Europe Bipolar Disorder Market Size Growth Rate (2018-2029) & (US$ Million)

Figure 7. Asia-Pacific Bipolar Disorder Market Size Growth Rate (2018-2029) & (US$ Million)

Figure 8. Latin America Bipolar Disorder Market Size Growth Rate (2018-2029) & (US$ Million)

Figure 9. Middle East & Africa Bipolar Disorder Market Size Growth Rate (2018-2029) & (US$ Million)

Figure 10. Product Picture of Bipolar I Disorder

Figure 11. Global Bipolar I Disorder Market Size (US$ Million) & YoY Growth (2018-2029)

Figure 12. Product Picture of Bipolar II Disorder

Figure 13. Global Bipolar II Disorder Market Size (US$ Million) & YoY Growth (2018-2029)

Figure 14. Product Picture of Cyclothymic Disorder

Figure 15. Global Cyclothymic Disorder Market Size (US$ Million) & YoY Growth (2018-2029)

Figure 16. Global Bipolar Disorder Market Size Share by Type: 2022 & 2029

Figure 17. North America Bipolar Disorder Revenue Market Share by Type (2018-2029)

Figure 18. Europe Bipolar Disorder Revenue Market Share by Type (2018-2029)

Figure 19. Asia-Pacific Bipolar Disorder Revenue Market Share by Type (2018-2029)

Figure 20. Latin America Bipolar Disorder Revenue Market Share by Type (2018-2029)

Figure 21. Middle East and Africa Bipolar Disorder Revenue Market Share by Type (2018-2029)

Figure 22. Mood Stabilizers Market Size (US$ Million) & YoY Growth (2018-2029)

Figure 23. Anticonvulsants Market Size (US$ Million) & YoY Growth (2018-2029)

Figure 24. Antipsychotic drugs Market Size (US$ Million) & YoY Growth (2018-2029)

Figure 25. Antidepressant drugs Market Size (US$ Million) & YoY Growth (2018-2029)

Figure 26. Antianxiety drugs Market Size (US$ Million) & YoY Growth (2018-2029)

Figure 27. Others Market Size (US$ Million) & YoY Growth (2018-2029)

Figure 28. Global Bipolar Disorder Market Size Share by Application: 2022 & 2029

Figure 29. North America Bipolar Disorder Revenue Market Share by Application (2018-2029)

Figure 30. Europe Bipolar Disorder Revenue Market Share by Application (2018-2029)

Figure 31. Asia-Pacific Bipolar Disorder Revenue Market Share by Application (2018-2029)

Figure 32. Latin America Bipolar Disorder Revenue Market Share by Application (2018-2029)

Figure 33. Middle East and Africa Bipolar Disorder Revenue Market Share by Application (2018-2029)

Figure 34. Bipolar Disorder Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022

Figure 35. Global Top 5 and Top 10 Players Bipolar Disorder Market Share in 2022

Figure 36. North America Bipolar Disorder Market Share by Country (2018-2029)

Figure 37. United States Bipolar Disorder Market Size (2018-2029) & (US$ Million)

Figure 38. Canada Bipolar Disorder Market Size (2018-2029) & (US$ Million)

Figure 39. Germany Bipolar Disorder Market Size (2018-2029) & (US$ Million)

Figure 40. France Bipolar Disorder Market Size (2018-2029) & (US$ Million)

Figure 41. U.K. Bipolar Disorder Market Size (2018-2029) & (US$ Million)

Figure 42. Italy Bipolar Disorder Market Size (2018-2029) & (US$ Million)

Figure 43. Russia Bipolar Disorder Market Size (2018-2029) & (US$ Million)

Figure 44. Nordic Countries Bipolar Disorder Market Size (2018-2029) & (US$ Million)

Figure 45. Asia-Pacific Bipolar Disorder Market Share by Region (2018-2029)

Figure 46. China Bipolar Disorder Market Size (2018-2029) & (US$ Million)

Figure 47. Japan Bipolar Disorder Market Size (2018-2029) & (US$ Million)

Figure 48. South Korea Bipolar Disorder Market Size (2018-2029) & (US$ Million)

Figure 49. Southeast Asia Bipolar Disorder Market Size (2018-2029) & (US$ Million)

Figure 50. India Bipolar Disorder Market Size (2018-2029) & (US$ Million)

Figure 51. Australia Bipolar Disorder Market Size (2018-2029) & (US$ Million)

Figure 52. Latin America Bipolar Disorder Market Share by Country (2018-2029)

Figure 53. Mexico Bipolar Disorder Market Size (2018-2029) & (US$ Million)

Figure 54. Brazil Bipolar Disorder Market Size (2018-2029) & (US$ Million)

Figure 55. Middle East & Africa Bipolar Disorder Market Share by Country (2018-2029)

Figure 56. Turkey Bipolar Disorder Market Size (2018-2029) & (US$ Million)

Figure 57. Saudi Arabia Bipolar Disorder Market Size (2018-2029) & (US$ Million)

Figure 58. UAE Bipolar Disorder Market Size (2018-2029) & (US$ Million)

Figure 59. Bottom-up and Top-down Approaches for This Report

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$3350

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$5025

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$6700

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions